JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 1987; 9:509-514
© 1987 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roy, D
Right arrow Articles by Cantin, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roy, D
Right arrow Articles by Cantin, M

Atrial natriuretic factor during atrial fibrillation and supraventricular tachycardia

D Roy, F Paillard, D Cassidy, MG Bourassa, J Gutkowska, J Genest, and M Cantin

Plasma immunoreactive atrial natriuretic factor was measured in 10 patients with chronic atrial fibrillation before and after cardioversion to sinus rhythm, and in 14 patients during electrophysiologic evaluation of paroxysmal supraventricular tachycardia. The mean plasma concentration of atrial natriuretic factor in atrial fibrillation was 138 +/- 48 pg/ml and decreased to 116 +/- 45 pg/ml 1 hour after cardioversion to sinus rhythm (p less than 0.005). The mean plasma concentration of atrial natriuretic factor increased from 117 +/- 53 pg/ml in sinus rhythm to 251 +/- 137 pg/ml during laboratory-induced supraventricular tachycardia (p less than 0.005). Right atrial pressures were recorded in 12 patients; the baseline atrial pressure was 4.3 +/- 1.9 mm Hg and increased to 7.4 +/- 3.6 mm Hg during supraventricular tachycardia (p less than 0.005). A modest but significant linear relation was noted between the changes in plasma atrial natriuretic factor and right atrial pressure measurements during induced supraventricular tachycardia (r = 0.60, p less than 0.05). In conclusion, changes in atrial rhythm and pressure may be an important factor modulating the release of atrial natriuretic factor in the circulation and raised levels of this hormone may be a contributing factor for the polyuria and the hypotension associated with paroxysmal supraventricular tachyarrhythmias.


This article has been cited by other articles:


Home page
EuropaceHome page
T. Yamada, Y. Murakami, T. Okada, N. Yoshida, J. Toyama, Y. Yoshida, N. Tsuboi, Y. Inden, M. Hirai, and T. Murohara
Plasma brain natriuretic peptide level after radiofrequency catheter ablation of paroxysmal, persistent, and permanent atrial fibrillation
Europace, September 1, 2007; 9(9): 770 - 774.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
P. T. Ellinor, A. F. Low, and C. A. MacRae
Reduced apelin levels in lone atrial fibrillation
Eur. Heart J., January 2, 2006; 27(2): 222 - 226.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
O Leone, G Boriani, B Chiappini, D Pacini, G Cenacchi, S Martin Suarez, C Rapezzi, M.L Bacchi Reggiani, and G Marinelli
Amyloid deposition as a cause of atrial remodelling in persistent valvular atrial fibrillation
Eur. Heart J., July 2, 2004; 25(14): 1237 - 1241.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
M. P. van den Berg, I. C. van Gelder, and D. J. van Veldhuisen
Depletion of atrial natriuretic peptide during longstanding atrial fibrillation
Europace, January 1, 2004; 6(5): 433 - 437.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
S Kamath, A D Blann, B S P Chin, and G Y H Lip
Platelet activation, haemorheology and thrombogenesis in acute atrial fibrillation: a comparison with permanent atrial fibrillation
Heart, September 1, 2003; 89(9): 1093 - 1095.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
B. Wozakowska-Kaplon and G. Opolski
Concomitant recovery of atrial mechanical and endocrine function after cardioversion in patients with persistent atrial fibrillation
J. Am. Coll. Cardiol., May 21, 2003; 41(10): 1716 - 1720.
[Abstract] [Full Text] [PDF]


Home page
Canadian J. AnesthesiaHome page
A. Nagatani, S. Niiya, and K. Sumikawa
High frequency jet ventilation is associated with increased levels of plasma {alpha}-atrial natriuretic peptide - a preliminary study: [La ventilation en jet a haute frequence est associee a une augmentation des niveaux plasmatiques de peptides natriuretiques auriculaires {alpha} - une etude preliminaire]
Can J Anesth, May 1, 2002; 49(5): 517 - 521.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
F. Yoshihara, T. Nishikimi, Y. Sasako, J. Hino, J. Kobayashi, K. Minatoya, K. Bando, Y. Kosakai, T. Horio, S.-i. Suga, et al.
Plasma atrial natriuretic peptide concentration inversely correlates with left atrial collagen volume fraction in patients with atrial fibrillation: Plasma ANP as a possible biochemical marker to predict the outcome of the maze procedure
J. Am. Coll. Cardiol., January 16, 2002; 39(2): 288 - 294.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Rossi, M. Enriquez-Sarano, J. C. Burnett Jr., A. Lerman, M. D. Abel, and J. B. Seward
Natriuretic peptide levels in atrial fibrillation: A prospective hormonal and Doppler-echocardiographic study
J. Am. Coll. Cardiol., April 1, 2000; 35(5): 1256 - 1262.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
K.-B. Kim, C.-H. Lee, C.-H. Kim, Y.-J. Cha, S. :, and J. L. Cox
Effect of the Cox maze procedure on the secretion of atrial natriuretic peptide
J. Thorac. Cardiovasc. Surg., January 1, 1998; 115(1): 139 - 147.
[Abstract] [Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 1987 by the American College of Cardiology Foundation.